FIELD: biotechnology.
SUBSTANCE: method for the treatment or prevention of at least one condition of postnatal depression (hereinafter – PND) and postnatal anxiety (hereinafter – PNA) in a subject representing a female adult and a method for the treatment or prevention of the occurrence of one or more risks associated with at least one of PND or PNA or its consequences in a subject representing a fetus, newborn, infant or child are proposed, including the injection of Lactobacillus rhamnosus HN001 AGAL NM97/09514 to a subject representing a mother of a fetus, newborn, infant or child in need of it; the use of Lactobacillus rhamnosus HN001 AGAL NM97/09514 in the production of a composition or a drug for the treatment or prevention of at least one of PND and PNA or one or more risks associated with PND and PNA, or their consequences (options).
EFFECT: inventions provide a reduction in the prevalence of symptoms of depression and anxiety during pregnancy and after childbirth.
18 cl, 1 dwg, 2 tbl, 1 ex
